Treatment Outcomes with Telaprevir-Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients

• Conar R O’Neil,
• Jack XQ Pang,
• Samuel S Lee,
• Mark G Swain,
• Kelly W Burak,
• Patricia Klein,
• Robert P Myers,
• Jeff Kapler,
• Michael J Gill,
• Martin Labrie,
• Carla S Coffin

Affiliations

Conar R O’Neil

Department of Internal Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Jack XQ Pang

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Samuel S Lee

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Mark G Swain

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Kelly W Burak

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Patricia Klein

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Robert P Myers

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Jeff Kapler

Southern Alberta Clinic, Calgary, Alberta, Canada

Michael J Gill

Southern Alberta Clinic, Department of Microbiology, Immunology and Infectious Diseases, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Martin Labrie

Southern Alberta Clinic, Department of Family Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada

Carla S Coffin

Calgary Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada